News
-
-
-
-
PRESS RELEASE
CTT Pharma Adds Independent Director With NIH/NSF Experience
CTT Pharmaceuticals Holdings, Inc. welcomes Dr. Katherine Cole, a highly accomplished professional with a Ph.D. in Pathology, as an Independent Director. Dr. Cole's extensive experience in cancer research and academia brings valuable insight to CTT -
-
-
-
-
-
PRESS RELEASE
Retransmission: CTT Pharma and Johns Hopkins University Submits Proposal for $15 Million NIH Grant for Smoking Cessation
CTT Pharma & Johns Hopkins University submit NIH Grant proposal for smoking cessation using CTT technology. CEO Khouri aims to offer innovative nicotine strips. NIH review in Apr 2025